Direct-to-Consumer Testing: Benefits and Concerns of Commercially Accessed Laboratory Tests

Area of Science:

• Clinical Chemistry
• Laboratory Medicine
• Health Services Research

Background:

• Patient self-empowerment is shifting laboratory test initiation from healthcare professionals to individuals.
• Direct-to-consumer testing (DTCT) operates outside traditional healthcare systems, lacking established patient protections.
• Aggressive DTCT marketing can mislead consumers, potentially causing psychological, physical, and financial harm.

Purpose of the Study:

• To analyze the implications of direct-to-consumer testing (DTCT) in contemporary healthcare.
• To evaluate the benefits and risks associated with patients initiating laboratory tests directly.
• To assess the impact of DTCT on patient empowerment and healthcare system trust.

Main Methods:

• Review of current literature on direct-to-consumer laboratory testing.
• Analysis of regulatory frameworks and consumer protection measures relevant to DTCT.
• Examination of potential psychological, physical, and financial consequences for consumers using DTCT.

Main Results:

• DTCT offers patient empowerment but is often marketed without adequate consumer information or oversight.
• The benefits of laboratory testing depend on appropriate application, sample handling, and result interpretation, which may be compromised in DTCT.
• Consumer knowledge regarding DTCT is variable, with a lack of reliable resources for guidance.

Conclusions:

• DTCT presents a substantial risk of medicalizing healthy individuals and undermining trust in laboratory testing reliability.
• While DTCT may offer advantages in specific scenarios, its unregulated nature poses significant threats to consumer well-being.
• The absence of healthcare protection rules and concurrent consumer information during DTCT marketing is a critical concern.